Phase IV, observational, post-authorization, cross sectional, open-label, multicenter study to evaluate the acceptability of oral solution of levetiracetam in patients with partial epilepsy as assessed by a questionnaire.

Inclusion Criteria:

• Patients 16 years old or older diagnosed with partial epilepsy with or without generalization receiving levetiracetam oral solution for at least 28 days before the study

Exclusion Criteria:

• Patients with disturbances of the sense of taste and smell that can interfere with the assessment of the parameters of the study

Study populaton is defined. See Eligibility Criteria.